Paradigm Capital Management Inc. NY Buys New Position in Concentrix Corporation $CNXC

Paradigm Capital Management Inc. NY purchased a new position in Concentrix Corporation (NASDAQ:CNXCFree Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 30,442 shares of the company’s stock, valued at approximately $682,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of CNXC. Royal Bank of Canada boosted its holdings in shares of Concentrix by 9.5% in the 1st quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock valued at $2,643,000 after buying an additional 4,133 shares in the last quarter. Goldman Sachs Group Inc. grew its position in shares of Concentrix by 75.1% in the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock valued at $23,552,000 after purchasing an additional 181,546 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Concentrix by 17.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock valued at $8,152,000 after purchasing an additional 21,746 shares during the last quarter. Focus Partners Wealth purchased a new stake in shares of Concentrix in the first quarter valued at $781,000. Finally, Geneos Wealth Management Inc. raised its position in shares of Concentrix by 532.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after buying an additional 522 shares during the period. Institutional investors and hedge funds own 90.34% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on CNXC shares. Zacks Research cut Concentrix from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 2nd. Barrington Research reduced their price target on Concentrix from $38.00 to $30.00 and set an “outperform” rating for the company in a research report on Tuesday, June 30th. Bank of America cut their target price on Concentrix from $32.00 to $26.00 and set a “neutral” rating for the company in a research report on Tuesday, June 30th. Canaccord Genuity Group dropped their price target on Concentrix from $55.00 to $45.00 and set a “buy” rating on the stock in a research note on Tuesday, June 30th. Finally, Robert W. Baird lowered their target price on Concentrix from $40.00 to $30.00 and set an “outperform” rating on the stock in a research note on Tuesday, June 30th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Concentrix presently has an average rating of “Hold” and a consensus price target of $32.75.

Get Our Latest Stock Analysis on Concentrix

Concentrix Trading Up 2.5%

Shares of Concentrix stock opened at $26.03 on Tuesday. The firm’s 50 day simple moving average is $24.42 and its two-hundred day simple moving average is $27.37. The firm has a market capitalization of $1.59 billion, a price-to-earnings ratio of -1.22, a PEG ratio of 0.47 and a beta of 0.45. Concentrix Corporation has a 12-month low of $19.12 and a 12-month high of $57.88. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 1.46.

Concentrix (NASDAQ:CNXCGet Free Report) last issued its earnings results on Monday, June 29th. The company reported $2.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). The firm had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.47 billion. Concentrix had a positive return on equity of 19.82% and a negative net margin of 13.16%.The business’s revenue was up 1.9% on a year-over-year basis. During the same quarter last year, the business earned $2.70 EPS. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. Analysts predict that Concentrix Corporation will post 9.67 EPS for the current year.

Concentrix Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, August 4th. Stockholders of record on Friday, July 24th were paid a $0.36 dividend. The ex-dividend date was Friday, July 24th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 5.5%. Concentrix’s dividend payout ratio is presently -6.75%.

About Concentrix

(Free Report)

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.

See Also

Want to see what other hedge funds are holding CNXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Concentrix Corporation (NASDAQ:CNXCFree Report).

Institutional Ownership by Quarter for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.